Pluri’s Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences
March 28, 2024 07:15 ET
|
Pluri Inc.
HAIFA, Israel, March 28, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) ("Pluri" or "the Company"), a leading biotechnology company that transforms cells into solutions that promote...
Gilat Awarded $5 Million Order from the US Department of Defense
March 28, 2024 07:06 ET
|
Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, March 28, 2024 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services,...
Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing
March 28, 2024 07:05 ET
|
Xilio Therapeutics, Inc.
Announces strategic portfolio reprioritization focused on rapid advancement of clinical-stage programs for XTX301, a tumor-activated, IL-12, and XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4, and...
Shimmick Corporation Announces Fourth Quarter and Fiscal Year 2023 Results
March 28, 2024 07:00 ET
|
Shimmick Corporation
IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Shimmick Corp. (NASDAQ: SHIM), a leading water infrastructure company, today announced financial results for the fiscal year ended December 29,...
atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights
March 28, 2024 07:00 ET
|
atai Life Sciences
Strategic investment in Beckley Psytech to accelerate the development of psychedelic-based therapies that fit within the two hour in-clinic treatment paradigm established by Spravato®Initial BPL-003...
Stran & Company Reports 28.7% Increase in Sales and Achieves Profitability for the 2023 Fiscal Year
March 28, 2024 07:00 ET
|
Stran & Company, Inc.
Benefitting from Increased Operating Efficiency and Economies of Scale, Evidenced by 156% Year-Over-Year Increase in Operating Income for the Fourth Quarter of 2023 Reports Net Earnings of $883,000...
Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates
March 28, 2024 07:00 ET
|
Galera Therapeutics
MALVERN, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a biopharmaceutical company focused on developing a pipeline of novel, proprietary therapeutics that have...
Milestone Pharmaceuticals Announces Resubmission of New Drug Application for Etripamil for Treatment in Paroxysmal Supraventricular Tachycardia
March 28, 2024 07:00 ET
|
Milestone Pharmaceuticals Inc.
MONTREAL and CHARLOTTE, N.C., March 28, 2024 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of...
ECARX Partners with Lianyou Zhilian to Accelerate Development of Intelligent Vehicle Solutions
March 28, 2024 07:00 ET
|
ECARX LIMITED; Lianyou Zhilian
SHANGHAI, China, March 28, 2024 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility technology provider, today announced a strategic partnership with...
Tilray Brands, Inc. to Announce Third Quarter 2024 Financial Results on April 9, 2024
March 28, 2024 07:00 ET
|
Tilray Brands, Inc.
Tilray Brands will release financial results for its third quarter ended February 29, 2024, on April 9, 2024.